Nalan Ogan

8PUBLICATIONS
29CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Clinical pharmacology and therapeuticsMajor global burdens of diseasePacific Peoples social determinants of healthOptometry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 10, 2024
Can the ADO Index Be Used as a Predictor of Mortality from COVID-19 in Patients with COPD?

Esra Ertan Yazar, Gulsah Gunluoglu, Burcu Arpinar Yigitbas

|Feb 24, 2024
Long-acting B-2 agonists (LABA) or long-acting muscarinic antagonists (LAMA): which one may be the first option in group A COPD patients?

Onur Turan, Nalan Ogan, Fulsen Bozkus

|Oct 08, 2020
The Effect of Serum Electrolyte Disturbances and Uric Acid Level on the Mortality of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Nalan Ogan, Ersin Günay, Ayşe Baha

|Mar 13, 2020
Does Nutritional Risk Screening 2002 Correlate with the Dyspnea Status of Patients with GOLD Stage C-D Chronic Obstructive Pulmonary Disease?

Nalan Ogan, Fatma Yıldırım, Banu Süzen

|Dec 29, 2019
Correlatıon of neutrophyle/lymphocyte ratio and pulmonary parameters with optic coherence tomography findings in stable chronic obstructive pulmonary disease.

Pinar Altiaylik Ozer, Nalan Ogan

|Aug 15, 2019
Do N-terminal pro-brain natriuretic peptide levels determine the prognosis of community acquired pneumonia?

Evrim Eylem Akpınar, Derya Hoşgün, Serdar Akpınar

Pageof 2

Frequent Collaborators

4 joint publications

Can Ateş

4 joint publications

Evrim Eylem Akpınar

3 joint publications

Onur Turan

2 joint publications

Fulsen Bozkus